Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance-Reference-Cited by-同舟云学术

Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance

Published:2023-11-14 Issue: Volume: Page:1-11
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Alloush Roba¹²^ORCID,van Lint Jette¹^ORCID,van Marum Rob J.³⁴,Hermens Walter W.A.J.J.⁵,Jessurun Naomi T.¹

Affiliation:

1. The Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The Netherlands

2. Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands

3. Jeroen Bosch Hospital, Department of Clinical Pharmacology, ‘s-Hertogenbosch, The Netherlands

4. Amsterdam UMC, Department of Geriatric Medicine, Amsterdam, The Netherlands

5. Jeroen Bosch Hospital, Department of Hospital Pharmacy, ‘s-Hertogenbosch, The Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2282582

Reference24 articles.

1. World Health Organization‎. The importance of pharmacovigilance. 2002. [cited 2022 Feb 14]. Available from: https://www.who.int/publications/i/item/10665-42493

2. European-Medicines-Agency. Guideline on Good Pharmacovigilance Practices (GVP): Annex 1. EMA/876333/2011 Rev 4. [cited 2022 Feb 14] Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/05/WC500143294.pdf.

3. European Commission. Proposal for a regulation amending as regards pharmacovigilance of medicinal products for human use. Regulation (EC) no 726/2004. Impact Assessment. 2008. [cited 2022 Feb 14]. Available at: http://ec.europa.eu/health/files/pharmacos/pharmpack_12_2008/pharmacovigilance-ia-vol1_en.pdf

4. Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis

5. Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study